• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

佩洛利昔 A 在缺氧条件下诱导 HCT116 结直肠癌细胞死亡依赖于 p53。

Peloruside A-Induced Cell Death in Hypoxia Is p53 Dependent in HCT116 Colorectal Cancer Cells.

机构信息

Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry , Palacky University , Hnevotinska 5 , 77900 Olomouc , Czech Republic.

School of Biological Sciences and Centre for Biodiscovery , Victoria University of Wellington , Wellington 6012 , New Zealand.

出版信息

J Nat Prod. 2018 Mar 23;81(3):634-640. doi: 10.1021/acs.jnatprod.7b00961. Epub 2018 Feb 5.

DOI:10.1021/acs.jnatprod.7b00961
PMID:29400463
Abstract

HCT116 colorectal cancer cell sensitivity to peloruside A (PLA) in normoxia is not altered by hypoxia preconditioning of the cells. We examined whether the PLA effects were altered in hypoxia and whether the activity was dependent on p53. The cytotoxicity of PLA in wild-type HCT116 cells was largely unaffected by hypoxia; however, cells in which p53 was knocked out showed resistance. Knockout of the p21 gene had little effect on the activity of PLA in hypoxia. It was concluded that the response of cells to the microtubule-stabilizing agent PLA under hypoxic conditions is a p53-dependent process.

摘要

在常氧条件下,HCT116 结直肠癌细胞对佩洛利德 A(PLA)的敏感性不受细胞缺氧预处理的影响。我们研究了在缺氧条件下 PLA 的作用是否发生改变,以及该活性是否依赖于 p53。在野生型 HCT116 细胞中,PLA 的细胞毒性在很大程度上不受缺氧的影响;然而,敲除 p53 的细胞则表现出耐药性。在缺氧条件下,敲除 p21 基因对 PLA 的活性几乎没有影响。结论是,细胞对微管稳定剂 PLA 的反应在缺氧条件下是一个依赖 p53 的过程。

相似文献

1
Peloruside A-Induced Cell Death in Hypoxia Is p53 Dependent in HCT116 Colorectal Cancer Cells.佩洛利昔 A 在缺氧条件下诱导 HCT116 结直肠癌细胞死亡依赖于 p53。
J Nat Prod. 2018 Mar 23;81(3):634-640. doi: 10.1021/acs.jnatprod.7b00961. Epub 2018 Feb 5.
2
Cellular effects of the microtubule-targeting agent peloruside A in hypoxia-conditioned colorectal carcinoma cells.缺氧条件下微管靶向药物 peloruside A 对结肠直肠癌细胞的细胞作用。
Biochim Biophys Acta Gen Subj. 2017 Jul;1861(7):1833-1843. doi: 10.1016/j.bbagen.2017.03.023. Epub 2017 Mar 31.
3
Cell death by the quinoxaline dioxide DCQ in human colon cancer cells is enhanced under hypoxia and is independent of p53 and p21.二氯亚硝基亚乙烯基脲(DCQ)诱导人结肠癌细胞死亡在缺氧条件下增强,且不依赖于 p53 和 p21。
Radiat Oncol. 2010 Nov 15;5:107. doi: 10.1186/1748-717X-5-107.
4
βI-tubulin mutations in the laulimalide/peloruside binding site mediate drug sensitivity by altering drug-tubulin interactions and microtubule stability.βI-微管蛋白突变位于 laulimalide/peloruside 结合位点,通过改变药物与微管蛋白的相互作用和微管稳定性来调节药物敏感性。
Cancer Lett. 2015 Sep 1;365(2):251-60. doi: 10.1016/j.canlet.2015.06.001. Epub 2015 Jun 4.
5
Induction of accelerated senescence by the microtubule-stabilizing agent peloruside A.微管稳定剂 peloruside A 诱导加速衰老。
Invest New Drugs. 2017 Dec;35(6):706-717. doi: 10.1007/s10637-017-0493-5. Epub 2017 Jul 22.
6
Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175.研究Bax、p21/Waf1和p53在暴露于新型细胞毒性钌(II)有机金属试剂RM175的HCT116结肠癌细胞中作为细胞反应决定因素的作用。
Cancer Chemother Pharmacol. 2005 Jun;55(6):577-83. doi: 10.1007/s00280-004-0932-9. Epub 2005 Feb 22.
7
Inhibition of human vascular endothelial cell migration and capillary-like tube formation by the microtubule-stabilizing agent peloruside A.微管稳定剂peloruside A对人血管内皮细胞迁移和毛细血管样管形成的抑制作用。
Invest New Drugs. 2015 Jun;33(3):564-74. doi: 10.1007/s10637-015-0232-8. Epub 2015 Mar 31.
8
Hypoxic resistance of KRAS mutant tumor cells to 3-Bromopyruvate is counteracted by Prima-1 and reversed by N-acetylcysteine.KRAS 突变肿瘤细胞对 3-溴丙酮酸的低氧抗性被 Prima-1 抵消,并被 N-乙酰半胱氨酸逆转。
BMC Cancer. 2016 Nov 18;16(1):902. doi: 10.1186/s12885-016-2930-9.
9
Acquired resistance to peloruside A and laulimalide is associated with downregulation of vimentin in human ovarian carcinoma cells.人卵巢癌细胞对佩罗利司他和拉罗曲班耐药与波形蛋白下调有关。
Pharm Res. 2012 Nov;29(11):3022-32. doi: 10.1007/s11095-012-0773-x. Epub 2012 May 15.
10
Microtubule stabilization by peloruside A and paclitaxel rescues degenerating neurons from okadaic acid-induced tau phosphorylation.佩乐来司他 A 和紫杉醇稳定微管可挽救 okadaic 酸诱导的 tau 磷酸化引起的神经元退变。
Eur J Neurosci. 2012 Jun;35(11):1705-17. doi: 10.1111/j.1460-9568.2012.08084.x. Epub 2012 May 17.

引用本文的文献

1
Pelophen B is a non-taxoid binding microtubule-stabilizing agent with promising preclinical anticancer properties.培洛芬B是一种非紫杉烷类结合型微管稳定剂,具有良好的临床前抗癌特性。
Sci Rep. 2024 Dec 4;14(1):30188. doi: 10.1038/s41598-024-80672-z.
2
Colorectal liver metastasis: molecular mechanism and interventional therapy.结直肠癌肝转移:分子机制与介入治疗。
Signal Transduct Target Ther. 2022 Mar 4;7(1):70. doi: 10.1038/s41392-022-00922-2.
3
Neuroprotective Approach of Anti-Cancer Microtubule Stabilizers Against Tauopathy Associated Dementia: Current Status of Clinical and Preclinical Findings.
抗癌微管稳定剂对tau蛋白病相关痴呆的神经保护方法:临床及临床前研究结果现状
J Alzheimers Dis Rep. 2019 Jul 2;3(1):179-218. doi: 10.3233/ADR-190125.